Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Recruiting
Phase 2
Interventional Study
Thyroid Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 13 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 62 (estimated)
- Sponsor
- Thomas Hope · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Persons diagnosed with thyroid cancer are often treated initially with a thyroidectomy, which is followed by ablation using Iodine-131, a therapy which has been shown to be effective and safe. Imaging of metastatic thyroid cancer has been performed with whole body I-131 and Iodine 123 (I-123) imaging for many decades and use I-123 for staging studies. Iodine 124 (I-124) is a radioisotope of iodine…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age \>= 13 years.
2. Histopathologically confirmed differentiated or poorly differentiated thyroid cancer.
3. Meeting criteria for one of the following two populations:
1. American Thyroid Association (ATA) intermediate or high-risk thyroid cancer and planning on treatmen…
Contacts